Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized prospective cross over study on the effects of medium cut-off membranes on T cellular and serologic immune phenotypes in hemodialysis.
Lorenz G, Shen Y, Hausinger RI, Scheid C, Eckermann M, Hornung S, Cardoso J, Lech M, Ribeiro A, Haller B, Holzmann-Littig C, Steubl D, Braunisch MC, Günthner R, Poschenrieder A, Freitag B, Weber M, Luppa P, Heemann U, Schmaderer C. Lorenz G, et al. Among authors: scheid c. Sci Rep. 2022 Sep 30;12(1):16419. doi: 10.1038/s41598-022-20818-z. Sci Rep. 2022. PMID: 36180564 Free PMC article. Clinical Trial.
Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial.
Leypoldt LB, Guo L, Besemer B, Hänel M, Raab MS, Mann C, Michel CS, Reinhardt HC, Blau IW, Görner M, Ko YD, de Wit M, Salwender H, Scheid C, Graeven U, Peceny R, Staib P, Dieing A, Goldschmidt H, Bokemeyer C, Zeller T, Westermann D, Weisel KC, Twerenbold R, Beitzen-Heineke A. Leypoldt LB, et al. Among authors: scheid c. Cardiooncology. 2025 Jul 3;11(1):63. doi: 10.1186/s40959-025-00358-x. Cardiooncology. 2025. PMID: 40611354
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.
Merz M, Gagelmann N, Smaili S, Flossdorf S, Sauer S, Scheid C, von Tresckow B, Wulf GG, Weisel KC, Blau I, Engelhardt M, Wäsch R, Schub N, Teipel R, Hecker JS, Waldschmidt JM, Besemer B, Baermann BN, Call S, Hansmann L, Ayuk FA, Raab MS, Einsele H, Platzbecker U, Kröger N. Merz M, et al. Among authors: scheid c. Blood. 2025 Jun 12:blood.2025028330. doi: 10.1182/blood.2025028330. Online ahead of print. Blood. 2025. PMID: 40504993
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study.
Cremer LM, Bethe U, Borchmann P, Di Cristanziano V, Gieselmann L, Grimm S, Hellmich M, Jakobs J, Nacov JA, Neuhann JM, Prattes J, Scheid C, Sprute R, Steger G, Stemler J, Mellinghoff SC, Cornely OA. Cremer LM, et al. Among authors: scheid c. JMIR Res Protoc. 2025 May 26;14:e60675. doi: 10.2196/60675. JMIR Res Protoc. 2025. PMID: 40418566 Free PMC article.
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Polverelli N, Hernández-Boluda JC, Onida F, Gurnari C, Raj K, Czerw T, Kenyon M, Robin M, Sockel K, Ruggeri A, Sánchez-Ortega I, Arber DA, Arcaini L, Duarte FB, Battipaglia G, Chalandon Y, Ciceri F, Cross NCP, Drozd-Sokolowska J, Funke V, Gagelmann N, Gangat N, Gotlib J, Guglielmelli P, Harrison C, Hobbs G, Jain T, Khoury JD, Kiladjian JJ, Kröger N, Malcovati L, Martino M, Mesa R, Orazi A, Padron E, Palandri F, Passamonti F, Patnaik MM, Pemmaraju N, Radia DH, Reiter A, Russo D, Scheid C, Tefferi A, Vannucchi AM, Wiseman DH, Yakoub-Agha I, McLornan DP. Polverelli N, et al. Among authors: scheid c. Blood. 2025 May 29;145(22):2561-2573. doi: 10.1182/blood.2024028000. Blood. 2025. PMID: 40106773 Free article. Review.
361 results